|
Volumn 58, Issue 5, 2002, Pages 353-356
|
Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy
a a c a a a b a a |
Author keywords
Morphine; UGT1A1; UGT2B7
|
Indexed keywords
ANALGESIC AGENT;
DNA FRAGMENT;
GLUCURONOSYLTRANSFERASE;
ISOENZYME;
MORPHINE;
MORPHINE 3 GLUCURONIDE;
MORPHINE 6 GLUCURONIDE;
ADULT;
AGED;
ALLELE;
ARTICLE;
CANCER PAIN;
CANCER PATIENT;
CONTROLLED STUDY;
DELAYED DRUG RELEASE;
DRUG BLOOD LEVEL;
FEMALE;
GENE AMPLIFICATION;
GENE EXPRESSION;
GENE IDENTIFICATION;
GENETIC POLYMORPHISM;
GENETIC VARIABILITY;
GENOTYPE;
HETEROZYGOSITY;
HOMOZYGOSITY;
HUMAN;
KIDNEY FUNCTION;
LIVER FUNCTION;
MAJOR CLINICAL STUDY;
MALE;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
RESTRICTION MAPPING;
WILD TYPE;
ADULT;
AGED;
AGED, 80 AND OVER;
ANALGESICS, OPIOID;
GENOTYPE;
GLUCURONOSYLTRANSFERASE;
HUMANS;
ISOENZYMES;
MIDDLE AGED;
MORPHINE;
MORPHINE DERIVATIVES;
NEOPLASMS;
PAIN;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
|
EID: 0036373740
PISSN: 00316970
EISSN: None
Source Type: Journal
DOI: 10.1007/s00228-002-0490-1 Document Type: Article |
Times cited : (128)
|
References (22)
|